Rybrevant

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 57894-501
  • Package NDC 57894-501-01
  • Application number BLA761210
  • SPL ID ce70b7e6-860b-49b8-8d74-c2a0f8c88c21
  • SPL set ID 1466c070-9f97-4fa4-a955-6a6b59981fb8
  • UNII 0JSR7Z0NB6
  • RxCUI 2549734
  • RxCUI 2549739

What the source publishes

Labeler
Janssen Biotech, Inc.
Active ingredients
amivantamab-vmjw
Form
INJECTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:57894-501_ce70b7e6-860b-49b8-8d74-c2a0f8c88c21
{
  "name": "Rybrevant",
  "splId": "ce70b7e6-860b-49b8-8d74-c2a0f8c88c21",
  "labels": [
    {
      "setId": "1466c070-9f97-4fa4-a955-6a6b59981fb8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1466c070-9f97-4fa4-a955-6a6b59981fb8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1466c070-9f97-4fa4-a955-6a6b59981fb8"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Janssen Biotech, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, SINGLE-USE in 1 CARTON (57894-501-01)  / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00)",
      "package_ndc": "57894-501-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210521"
    }
  ],
  "productId": "57894-501_ce70b7e6-860b-49b8-8d74-c2a0f8c88c21",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "57894-501",
  "deaSchedule": null,
  "genericName": "amivantamab-vmjw",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "AMIVANTAMAB",
      "strength": "350 mg/1"
    }
  ],
  "applicationNumber": "BLA761210",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210521",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0357894501015"
    ],
    "unii": [
      "0JSR7Z0NB6"
    ],
    "rxcui": [
      "2549734",
      "2549739"
    ],
    "spl_set_id": [
      "1466c070-9f97-4fa4-a955-6a6b59981fb8"
    ],
    "manufacturer_name": [
      "Janssen Biotech, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:57894-501_ce70b7e6-860b-49b8-8d74-c2a0f8c88c21"